Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024

Stock Information for Avenue Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.